GGrantIndex
← Leaderboards

Sharon R. Pine

University Of Colorado Denver

$4,344,969
Attributed
$4,344,969
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $441.2K · FY201125
$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,344,969 · 3

By mechanism

R01$3,806,223 · 2
K22$538,746 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingTumorCessation Of LifeLung NeoplasmsIn VivoPathway InteractionsMalignant Neoplasm Of LungMalignant NeoplasmsTherapy ResistantAutomobile DrivingMutantMolecularLung AdenocarcinomaMutationTumor ProgressionClustered Regularly Interspaced Short Palindromic RepeatsOncogenicAddictionTranscription FactorXenograft ProcedureSignal TransductionNon-Small-Cell Lung CarcinomaMolecular ProfilingCancer Survival

Grant awards (16)

Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$433,114
R01 · FY2025 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$441,169
R01 · FY2024 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$373,775
R01 · FY2022 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$50,677
R01 · FY2022 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$430,226
R01 · FY2021 · CA · contact PI
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities$416,907
R01 · FY2020 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$323,486
R01 · FY2018 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$323,793
R01 · FY2017 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$40,000
R01 · FY2017 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$324,085
R01 · FY2016 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$324,363
R01 · FY2015 · CA · contact PI
Sox9 signaling in lung adenocarcinoma$324,628
R01 · FY2014 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$152,907
K22 · FY2013 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$26,675
K22 · FY2013 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$179,582
K22 · FY2012 · CA · contact PI
Asymmetric Cell Division and Notch Signaling in Lung Cancer Stem Cells$179,582
K22 · FY2011 · CA · contact PI